CRWD vs ISRG: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Intuitive Surgical, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-24.
CrowdStrike Holdings, Inc. Β· Technology
$436.32
+34.6% upside to fair value
Grade B
VS
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD ISRG
Current Price $436.32 $451.29
Fair Value Estimate $587.16 $654.37
Upside to Fair Value +34.6% +45.0%
Market Cap $110.7B $160.3B
Forward P/E -601.6x 53.8x
EV / EBITDA 951.5x 40.5x
Price / Sales 23.0x 15.2x
Price / FCF 89.3x 64.3x
Revenue Growth YoY +23.3% +23.0%
Gross Margin 74.9% 66.3%
Operating Margin -5.4% 30.5%
Return on Equity -4.7% 17.0%
Dividend Yield 0% 0%
FCF Yield 1.12% 1.55%
Analyst Consensus Buy Strong Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-based endpoint protection and threat intelligence, with a dominant subscription revenue model accounting for over 95% of total revenue. The business quality is medium due to strong revenue growth of 23.3% in the most recent quarter and a robust earnings growth of 141.9% in the same period, supported by a high gros…
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Accumulation Zones
Metric CRWD ISRG
Zone Low $440.37 $490.78
Zone High $499.09 $556.21
In Buy Zone? Yes Yes
← CRWD Research    ISRG Research β†’    All Research